Professor Roger Kirby MA MD FRCS (Urol)
Immediate Past President, Royal Society of Medicine and Vice President, Prostate Cancer UK
About this event
- Date and time Wed 27 Nov 2024 from 5:30pm to 6:30pm
- Location Online
Explore the current options for prostate cancer diagnosis and discuss promising future approaches at our next Spotlight webinar, with Professor Roger Kirby, Professor Mark Emberton, Professor Anwar Padhani and Professor Shonit Punwani.
Our key speakers will discuss the most recent findings in prostate cancer research and examine emerging treatment options for localised prostate cancer, considering their overall impact on patients.
Prostate cancer is the most common cancer for men in the UK, affecting 1 in 8 men during the course of their lifetime.* Symptoms often do not appear until the disease has reached an advanced stage, which can result in later diagnoses and limit treatment options. And yet in the UK, there is no national screening programme.
Awareness of prostate cancer has increased due to high profile figures such as Sir Chris Hoy and Stephen Fry sharing their stories. However, we must keep this momentum going and continue to raise awareness to ensure men are diagnosed at the earliest possible stage.
This spotlight episode aims to provide a comprehensive overview of the UK approach to prostate cancer diagnosis and treatment. Chaired by the distinguished urologist and leading expert in prostate cancer and urological health, Professor Roger Kirby, join us as we bring together key experts, clinicians, and researchers for an enlightening discussion to enhance your understanding and perspectives.
By attending this webinar, you will:
- Learn about the most recent findings in prostate cancer research
- Explore the current options for prostate cancer diagnosis and discuss promising future approaches
- Examine emerging treatment options for localised and metastatic prostate cancer, considering their overall impact on patients
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsor Prostate Cancer UK for their financial support of this meeting.
Tickets
Standard pricing available until 27 November 2024.
Member
| RSM Fellow | RSM Associate | RSM Student | RSM Trainee | RSM Retired Fellow |
|---|---|---|---|---|
| £30.00 | £30.00 | £30.00 | £30.00 | £30.00 |
Non - Member
| AHP / Nurse / Midwife | Consultant / GP / SAS Doctors | Student | Trainee |
|---|---|---|---|
| £42.00 | £42.00 | £42.00 | £42.00 |
Key speakers
Professor Mark Emberton
Dean, Faculty of Medical Sciences, University College London
Speaker's biography
Mark Emberton is Professor of Interventional Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London. He is clinically active and holds the position of Honorary Consultant Urologist at University College London Hospitals NHS Trust where he works as a specialist in prostate cancer.
His academic work has focused on developing novel diagnostic strategies and new therapies for men with prostate cancer. His research has resulted in the transformation of both the diagnostic and therapeutic pathways. These have been incorporated into international guidelines.
He has published over 500 peer review papers, holds a large grant portfolio, and lectures widely around the world and holds international honorary professorships.
He is a founding Pioneer of the charity Prostate Cancer UK.
Professor Anwar Padhani MBBS MRCP FRCR
Professor of Cancer Imaging, Institute of Cancer Research and Consultant Radiologist, Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust
Professor Shonit Punwani
Professor of Magnetic Resonance and Cancer Imaging and Consultant Radiologist, University College London Hospitals NHS Foundation Trust
Agenda
View the programme
Welcome and introduction
Professor Roger Kirby, Immediate Past President, Royal Society of Medicine and Vice President, Prostate Cancer UK
Interactive panel discussion
Chair: Professor Roger Kirby
Professor Mark Emberton, Dean, Faculty of Medical Sciences, University College London, Professor Anwar Padhani, Professor of Cancer Imaging, Institute of Cancer Research and Consultant Radiologist, Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust and Professor Shonit Punwani, Professor of Magnetic Resonance and Cancer Imaging and Consultant Radiologist, University College London Hospitals NHS Foundation Trust
Closing remarks
Professor Roger Kirby
Close of meeting
Sponsors
Location
Online
Registration for this webinar will close 1 hour prior to the start time. You will receive the webinar link 1 hour before the meeting. Late registrations will not be accepted.
Webinar recordings will be available for registered delegates up to 60 days after the live webinar, via Zoom. The link will be sent 24 hours after the webinar takes place.
This webinar will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
